Literature DB >> 22126492

Genetic polymorphisms of the CYP2E1 gene do not contribute to oral cancer susceptibility in south Indians.

Lakshmi Balaji1, Krishna Balaji Singh, L V K S Bhaskar.   

Abstract

Cytochrome P450 (CYP) is a super family of mixed-function oxidases that are responsible for the human metabolism of drugs and endogenous compounds, as well as environmental and dietary substances. Many CYP enzymes function in the liver, but presence of CYP2E1 in the brain is demonstrating its role in both nicotine and ethanol metabolism. To examine the association between CYP2E1 polymorphism and the risk of oral cancer, we performed a case-control study on a south Indian population. 157 patients with oral cancer and 132 age and sexmatched controls were recruited. Three SNPs of the CYP2E1 gene [4768G>A (p. V179I, dbSNP rs6413419), CYP2E1-1295G>C (dbSNP rs3813867) and CYP2E1_-1055C>T (dbSNP rs2031920)] were genotyped using TaqMan allelic discrimination. The V179I locus is monomorphic in the study subjects, whereas rs3813867 and rs2031920 are co-inherited with a minor allele frequency of 0.022. None of the polymorphic sites deviated from HWE in controls. A much lesser frequency of the uncommon c2 allele was seen in our control subjects than in Caucasians and East Asians. There were no significant differences between oral cancer and controls in the distribution of either allelic or genotype frequencies. None of the haplotypes showed a significant association with oral cancer. Our results suggest that CYP2E1 is not a major or independent determinant in the pathogenesis of oral cancer in south Indians.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22126492

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  CYP2E1 RsaI/PstI polymorphisms contributed to oral cancer susceptibility: a meta-analysis.

Authors:  Yang Guo; Shan Zhou; Feng Liu; Bin Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 2.  Polymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: susceptibility to head and neck cancers.

Authors:  Rim Khlifi; Olfa Messaoud; Ahmed Rebai; Amel Hamza-Chaffai
Journal:  Biomed Res Int       Date:  2013-09-16       Impact factor: 3.411

Review 3.  Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Chandrasekaran Adithan
Journal:  Indian J Med Res       Date:  2014-01       Impact factor: 2.375

Review 4.  Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies.

Authors:  Xianlu Zhuo; Jue Song; Jian Liao; Wei Zhou; Huiping Ye; Qi Li; Zhaolan Xiang; Xueyuan Zhang
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

5.  Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer.

Authors:  Jin Feng; Xiaolin Pan; Junbo Yu; Zheng Chen; Hao Xu; Wael El-Rifai; Guoxin Zhang; Zekuan Xu
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

6.  Analysis of the role of rs2031920 and rs3813867 polymorphisms within the cytochrome P450 2E1 gene in the risk of squamous cell carcinoma.

Authors:  Hai Zhang; Haiyan Li; Huanxin Yu
Journal:  Cancer Cell Int       Date:  2018-05-01       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.